VHIO-led study shows the preclinical promise of systemic targeted therapy in pseudomyxoma peritonei Credit: VHIO VHIO-led study shows the preclinical...
July 18, 2024, Nutley, NJ – The foundational science to develop an exhaled-breath test for detection of lung diseases including...
TAMPA, Fla. — The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for...
Announcing a new article publication for BIO Integration journal. The tumor microenvironment (TME) has a crucial role in tumor development,...
Manel Esteller, Group Leader at the Josep Carreras Leukaemia Research Institute, ICREA Research Professor and Chair of Genetics at the...
Researchers from Drexel’s College of Medicine have identified new drugs that show early success in shrinking breast cancer tumors that...
Rockville, MD – July 18, 2024 Rockville, MD – July 18, 2024 The National Foundation for Cancer Research (NFCR) announced...
In a report published in Nature Cell Biology, researchers at Baylor College of Medicine, Texas Children’s Hospital, the University of...
Relapsed/refractory acute myeloid leukemia (AML), a so-called blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs...
A landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at the U,...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine